ArticleCell cycle (Georgetown, Tex.)2020

MAFG-AS1 is a novel clinical biomarker for clinical progression and unfavorable prognosis in gastric cancer.

Chao Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.